Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(13%)
Results Posted
120%(6 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_1
4
50%
Ph phase_4
1
13%
Ph not_applicable
2
25%
Ph phase_2
1
13%

Phase Distribution

4

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (50.0%)
Phase 21 (12.5%)
Phase 41 (12.5%)
N/A2 (25.0%)

Trials by Status

terminated225%
completed563%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingnot_applicable

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

NCT01666080
completedphase_1

Levetiracetam 1000 mg Under Fasting Conditions

NCT00859521
completedphase_1

Levetiracetam 1000 mg Under Non-Fasting Conditions

NCT00859430
terminatednot_applicable

Busulfan and Cyclophosphamide Followed By ALLO BMT

NCT01685411
terminatedphase_2

Keppra for Cervical Dystonia

NCT00760318
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01666080Not Applicable

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Recruiting
NCT00859521Phase 1

Levetiracetam 1000 mg Under Fasting Conditions

Completed
NCT00859430Phase 1

Levetiracetam 1000 mg Under Non-Fasting Conditions

Completed
NCT01685411Not Applicable

Busulfan and Cyclophosphamide Followed By ALLO BMT

Terminated
NCT00760318Phase 2

Keppra for Cervical Dystonia

Terminated
NCT00510783Phase 4

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Completed
NCT00849862Phase 1

Levetiracetam 750 mg Tablets Under Fasting Conditions

Completed
NCT00849485Phase 1

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8